| Literature DB >> 33812370 |
Kan Wu1, Chunjie Li2, Zheng Yang3, Shangchun Yang1, Wenbing Yang1, Chengge Hua4.
Abstract
BACKGROUND: Further understanding of the distribution and changing characteristics of dental diseases is of great significance for all dental emergency centers for strengthening the medical staff's treatment knowledge abilities and effective use of emergency resources in the face of public health emergencies involving highly infectious respiratory diseases.Entities:
Keywords: Demographics; Dental emergency patients; Diagnoses; SARS-COV-2; Treatment
Year: 2021 PMID: 33812370 PMCID: PMC8019344 DOI: 10.1186/s12903-021-01499-y
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Fig. 1Distribution of patients by sex, age, day, and time
Diagnosis in relation to demographic characteristics
| Diagnosis | Pre-SARS-COV-2 group | During-SARS-COV-2 group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients n (%) | Mean age | Gender | Patients | Mean age | Gender | ||||||
| Male n (%) | Female n (%) | Male n (%) | Female n(5) | ||||||||
| Group1 | 413 (25.9%) | 31.4 ± 14.8 | 206 (49.9%) | 207 (50.1%) | 0.642 | 858 (35.1%) | 38.4 ± 17.9 | 423 (49.3%) | 435 (50.7%) | 0.339 | 0.000 |
| Group2 | 314 (18.2%) | 30.9 ± 12.2 | 121 (38.5%) | 193 (61.5%) | 0.000 | 529 (21.7%) | 32.8 ± 14.7 | 156 (39.2%) | 242 (60.8%) | 0.000 | 0.005 |
| Group3 | 24 (1.4%) | 31.8 ± 13.9 | 10 (41.7%) | 14 (58.3%) | 0.364 | 56 (2.3%) | 38.1 ± 26.0 | 33 (58.9%) | 23 (41.1%) | 0.008 | 0.043 |
| Group4 | 161 (9.6%) | 35.5 ± 15.1 | 80 (49.7%) | 81 (50.3%) | 0.752 | 227 (9.3%) | 40.7 ± 19.4 | 122 (53.7%) | 105 (46.3%) | 0.322 | 0.715 |
| Group5 | 695 (38.0%) | 15.2 ± 15.9 | 405 (58.3%) | 290 (41.7%) | 0.000 | 492 (20.1%) | 19.8 ± 17.9 | 286 (58.1%) | 206 (41.9%) | 0.000 | 0.000 |
| Group6 | 58 (3.2%) | 23.5 ± 12.1 | 31 (53.4%) | 27 (46.6%) | 0.729 | 23 (0.9%) | 32.2 ± 17.6 | 10 (43.5%) | 13 (56.5%) | 0.492 | 0.000 |
| Group7 | 51 (3.7%) | 26.5 ± 12.3 | 20 (39.2%) | 31 (60.8%) | 0.091 | 257 (10.5%) | 33.5 ± 21.0 | 127 (49.4%) | 130 (50.6%) | 0.685 | |
Group1: Acute Pulpitis (K04.0) and/or Acute apical periodontitis (K04.4)
Group2: Acute gingivitis (K05.0) and/or Acute pericoronitis (K05.2)
Group3: Temporomandibular joint disorders (K07.6)
Group4: Cellulitis and abscess of mouth (K12.2)
Group5: Open wound of lip and/or oral cavity (S01.5)
Group6: Fracture of tooth (S02.5)
Group7: Others (non-emergency diseases, including diagnoses related to prosthesis, aesthetic, recall or maintenance)
Use of Antibiotics and/or Analgesics and treatment by diagnosis
| Diagnosis | Patients n | Pre-SARS-COV-2 | Patients n | During-SARS-COV-2 | ||
|---|---|---|---|---|---|---|
| Antibiotics/Analgesics n(%) | local treatment n(%) | Antibiotics/Analgesics n (%) | Local treatment n (%) | |||
| Group1 | 413 | 45 (10.9%) | 364 (88.1%) | 858 | 219 (25.5%) | 583 (67.9%) |
| Group2 | 314 | 61 (19.4%) | 259 (82.5%) | 529 | 227 (44.9%) | 367 (69.4%) |
| Group3 | 24 | 1 (4.2%) | 7 (29.2%) | 56 | 2 (3.6%) | 10 (17.9%) |
| Group4 | 161 | 76 (47.2%) | 132 (82.0%) | 227 | 99 (43.6%) | 156 (68.7%) |
| Group5 | 695 | 103 (14.8%) | 655 (94.2%) | 492 | 208 (42.3%) | 474 (96.3%) |
| Group6 | 58 | 6 (6.1%) | 31 (53.4%) | 23 | 6 (26.1%) | 7 (30.4%) |
| Group7 | 51 | 12 (23.5%) | 37 (72.5%) | 257 | 197 (76.7%) | 39 (15.2%) |
Group1: Acute Pulpitis (K04.0) and/or Acute apical periodontitis (K04.4)
Group2: Acute gingivitis (K05.0) and/or Acute pericoronitis (K05.2)
Group3: Temporomandibular joint disorders (K07.6)
Group4: Cellulitis and abscess of mouth (K12.2)
Group5: Open wound of lip and/or oral cavity (S01.5)
Group6: Fracture of tooth (S02.5)
Group7: Others (non-emergency diseases, including diagnoses related to prosthesis, aesthetic, recall or maintenance)